Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Viragen completes toxicology studies of Omniferon

Feb. 5, 1999

Enzon initiates phase III trials of PEG-Intron/Rebetol combination therapy for hepatitis C

Feb. 3, 1999

Carrington announces plans for phase III testing of Aliminase

Jan. 28, 1999

Anti-TNF MAb reduces circulating levels of sPLA2 in Crohn's disease patients

Jan. 28, 1999

Disaccharidase inhibitor as adjunctive therapy in portal-systemic encephalopathy

Jan. 27, 1999

Patent coverage sought by Viragen for second-generation interferon product

Jan. 26, 1999

Preclinical study results support development of antiulcer agent TU-199

Jan. 26, 1999

Anti-H. pylori agents under investigation at Bayer

Jan. 26, 1999

Amide antibacterial agents with potential in gastric disorders in development at Mitsubishi

Jan. 26, 1999

Chinese herbal medicines prove effective in some IBS patients

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...